Eisner Mark 4
4 · FIBROGEN INC · Filed Apr 6, 2023
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Eisner Mark
Incoming Chief Medical Officer
Transactions
- Sale
Common Stock
2023-04-04$18.78/sh−9,182$172,473→ 165,994 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.